Open label, uncontrolled pilot study on the effect of mucosal healing with 3 g mesalazine granules in NSAID induced small bowel enteropathy, evaluated by video capsule endoscopy after 4 weeks of treatment. An investigator initiated phase II pilot study.
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2012
At a glance
- Drugs Mesalazine (Primary)
- Indications NSAID-induced gastrointestinal damage
- Focus Therapeutic Use
- 23 Jul 2011 New trial record